PROCÉDÉ DE DÉTECTION QUANTITATIVE ANTI-HBC ET UTILISATIONS DE CELUI-CI POUR LA SURVEILLANCE ET LE CONTRÔLE DE LA PROGRESSION DE LA MALADIE CHEZ UN PATIENT ATTEINT DE L'HÉPATITE B CHRONIQUE ET POUR EN PRÉDIRE UN EFFET THÉRAPEUTIQUE
The present invention relates to a method for quantitative detection of anti-HBc and its use in monitoring disease progression of chronic hepatitis B patients and predicting therapeutic effects. By quantitative detection of antibodies against hepatitis B core protein (Anti-HBc), it is able to monitor disease progression of chronic hepatitis B patients, effectively predict therapeutic effects in chronic hepatitis B patients who accept a therapy against hepatitis B virus (especially, a therapy based on interferon and a therapy based on nucleoside/nucleotide analogue anti-HBV drug), and thus guide the patients to reasonably choose drugs.
